-
August 11, 2022 by
Jennifer Nachbur
The Northern New England Clinical and Translational Research Network has received a $20 million-dollar renewal grant from the National Institutes of Health to continue work to ensure residents in Vermont and Maine – and particularly the elderly, New American and Indigenous populations – receive greater support to address chronic and life-threatening diseases.
-
March 7, 2022 by
Michelle Bookless
University of Vermont graduate students Dorcas Lohese, Sean Lenahan, Joseph Owuor, and Matt Mullen are the newest representatives for the UVM Larner College of Medicine Graduate Student Council. Hannah Despres, who served on the council for the 2020-2021 term, has been re-elected for another year.
-
January 18, 2022 by
Kate Strotmeyer
UVM Cancer Center researchers contributed to the establishment of a breast pre-cancer atlas, which establishes the molecular and cellular properties of early-stage breast cancer and is the result of a six-year, National Cancer Institute-funded, collaborative initiative.
-
January 26, 2022 by
Katherine Strotmeyer
The UVM Cancer Center Summer Student Fellowships in Cancer Research provide $3,000 stipends to graduate and medical students for cancer-related research projects, overseen by senior faculty members affiliated with the center.
-
January 15, 2021 by
Jennifer Nachbur
Medical education leaders and scholars gathered virtually on January 13 and 14, 2021 for the Larner College of Medicine Teaching Academy’s 2021 Induction and Award Ceremony and Snow Season Education Retreat. Co-presented with the University of Vermont Health Network Medical Group, the ceremony recognized medical educators and kicked off the annual education program, which this year featured several sessions on diversity, equity, and inclusion.
-
November 25, 2020 by
Kyra Chevalier
Three University of Vermont professors, include Professor of Biochemistry Christopher Francklyn, Ph.D., have been named Fellows of the American Association for the Advancement of Science (AAAS), the world’s largest multidisciplinary scientific society, for their outstanding contributions to science.
-
September 10, 2020 by
Jennifer Nachbur
The University of Vermont (UVM) is participating in a major national research effort to evaluate the safety and effectiveness of varying types of blood thinners to treat adults diagnosed and hospitalized with COVID-19—the disease caused by SARS-CoV-2.
-
May 8, 2020 by
Jennifer Nachbur
Larner College of Medicine faculty members Gregory Holmes, M.D., professor and chair of neurological sciences, and Gary Stein, Ph.D., Perelman professor and chair of biochemistry, have been selected as University Scholars for the 2020-21 academic year.
-
October 30, 2019 by
Jennifer Nachbur
The Larner College of Medicine's fourth annual "Celebrating Excellence in Research" series featured two days of presentations and recognition designed to highlight research performed by junior faculty, senior faculty, postdoctoral trainees, and graduate students at the College.
-
July 15, 2019 by
Heather McCabe
(JULY 15, 2019) Professor of Pathology and Laboratory Medicine Russell Tracy, Ph.D., was interviewed on WCAX-TV's "You Can Quote Me" program about the scope of the Larner College of Medicine at the University of Vermont’s involvement in the National Institutes of Health’s Risk Underlying Rural Areas Longitudinal (RURAL) Study.
-
May 22, 2019 by
Jennifer Nachbur
(May 22, 2019) In an effort to understand why some people born in rural communities in the South live shorter and less healthy lives than their counterparts elsewhere in the same counties as well as across the country, researchers from the Larner College of Medicine at the University of Vermont at 11 other institutions will be participating in a new longitudinal cohort study aimed at combating this issue - the Risk Underlying Rural Areas Longitudinal Study (RURAL) .
-
April 26, 2019 by
Jennifer Nachbur
(APRIL 26, 2019) Russell P. Tracy, Ph.D., professor of pathology & laboratory medicine and biochemistry at the Larner College of Medicine at the University of Vermont, is among three faculty members who were selected for recognition as a University of Vermont Distinguished Professor at the UVM Main Commencement ceremony on May 19, 2019.
-
April 8, 2019 by
Jennifer Nachbur
More than a dozen Larner College of Medicine faculty and scientists were recognized during the awards portion of the 14th annual Invention to Venture (I2V) conference April 5, 2019.
-
October 9, 2018 by
Jennifer Nachbur
An innovative initiative that will use a public health approach to inform opioid prescribing policies will be launched in northern New England thanks to a new $339,000 grant to the Northern New England Clinical and Translational Research (NNE-CTR) Network from the National Institutes of Health.
-
October 27, 2017 by
Jennifer Nachbur
Gary S. Stein, Ph.D., director of the University of Vermont Cancer Center, professor and chair of biochemistry and professor of surgery at the UVM Larner College of Medicine, was invested in a formal ceremony on October 27, 2017 as the inaugural Arthur Jason Perelman, M.D.’52 Professor in Cancer Research.
-
July 19, 2017 by
Jennifer Nachbur
-
July 13, 2017 by
Jennifer Nachbur
A five-year, $20 million National Institutes of Health (NIH) Clinical and Translational Research (CTR) Network grant will fund a joint program between the University of Vermont (UVM) and Maine Medical Center in Portland, Maine to develop and sustain a clinical and translational research infrastructure improving rural and community health for residents of Vermont, New Hampshire and Maine.
-
February 21, 2017 by
Jennifer Nachbur
University of Vermont Cancer Center members Jane Lian, Ph.D., and Janet Stein, Ph.D., have been elected Fellows of the American Association for the Advancement of Science (AAAS) in recognition of their contributions to innovation, education, and scientific leadership. The announcement of the AAAS 2016 Fellows was featured in the November 25, 2016 issue of Science.
-
November 11, 2015 by
Sarah Keblin
While better technology and screening practices have led to the detection of more breast cancers in women—many of which fall into a broad category of early-stage cancer, including ductal carcinoma in situ or DCIS—researchers still do not understand why some of these early cancers remain idle, while others progress. With the support of a new, $3.7 million federal grant from the National Cancer Institute (NCI), an interdisciplinary team of researchers at the University of Vermont (UVM) Cancer Center will be looking to answer this question.
Full story >>